Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Gastonguay

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Pharmaceutical Research|December 1, 1994
The use of multiple doses and pharmacodynamic system analysis to distinguish between dispositional delays and time-variant pharmacodynamicsM R Gastonguay, S L Schwartz
Clinical Pharmacology and Therapeutics|April 5, 2008
Mathematics for understanding diseaseR R Bies, M R Gastonguay, S L Schwartz
Immunopharmacology|March 1, 1992
Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibilityB M Bayer, M R Gastonguay, M C Hernandez
CPT: Pharmacometrics & Systems Pharmacology|October 10, 2015
Connecting the Dots: Linking Osteocyte Activity and Therapeutic Modulation of Sclerostin by Extending a Multiscale Systems ModelR J Eudy, M R Gastonguay, K T Baron, et al.
Journal of Clinical Pharmacology|May 21, 2010
Population pharmacokinetic modeling of pantoprazole in pediatric patients from birth to 16 yearsW Knebel, B Tammara, C Udata, et al.
Clinical Pharmacology and Therapeutics|January 29, 2010
Quantitative assessment of exposure-response relationships for the efficacy and tolerability of varenicline for smoking cessationP Ravva, M R Gastonguay, J L French, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 10, 2002
Population pharmacokinetics and pharmacodynamics of sotalol in pediatric patients with supraventricular or ventricular tachyarrhythmiaJ Shi, T M Ludden, A P Melikian, et al.
Drug Discoveries & Therapeutics|April 12, 2012
Exposure-response modeling and clinical trial simulation of the effect of tolterodine on QT intervals in healthy volunteersK R Sweeney, M R Gastonguay, L Benincosa, et al.
British Journal of Anaesthesia|January 15, 2015
Population pharmacokinetics of ϵ-aminocaproic acid in adolescents undergoing posterior spinal fusion surgeryP A Stricker, M R Gastonguay, D Singh, et al.
Alimentary Pharmacology & Therapeutics|May 22, 2015
Population pharmacokinetics-pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's diseaseM Rosario, N L Dirks, M R Gastonguay, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Pharmaceutical Research|December 1, 1994
The use of multiple doses and pharmacodynamic system analysis to distinguish between dispositional delays and time-variant pharmacodynamicsM R Gastonguay, S L Schwartz
Clinical Pharmacology and Therapeutics|April 5, 2008
Mathematics for understanding diseaseR R Bies, M R Gastonguay, S L Schwartz
Immunopharmacology|March 1, 1992
Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibilityB M Bayer, M R Gastonguay, M C Hernandez
CPT: Pharmacometrics & Systems Pharmacology|October 10, 2015
Connecting the Dots: Linking Osteocyte Activity and Therapeutic Modulation of Sclerostin by Extending a Multiscale Systems ModelR J Eudy, M R Gastonguay, K T Baron, et al.
Journal of Clinical Pharmacology|May 21, 2010
Population pharmacokinetic modeling of pantoprazole in pediatric patients from birth to 16 yearsW Knebel, B Tammara, C Udata, et al.
Clinical Pharmacology and Therapeutics|January 29, 2010
Quantitative assessment of exposure-response relationships for the efficacy and tolerability of varenicline for smoking cessationP Ravva, M R Gastonguay, J L French, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 10, 2002
Population pharmacokinetics and pharmacodynamics of sotalol in pediatric patients with supraventricular or ventricular tachyarrhythmiaJ Shi, T M Ludden, A P Melikian, et al.
Drug Discoveries & Therapeutics|April 12, 2012
Exposure-response modeling and clinical trial simulation of the effect of tolterodine on QT intervals in healthy volunteersK R Sweeney, M R Gastonguay, L Benincosa, et al.
British Journal of Anaesthesia|January 15, 2015
Population pharmacokinetics of ϵ-aminocaproic acid in adolescents undergoing posterior spinal fusion surgeryP A Stricker, M R Gastonguay, D Singh, et al.
Alimentary Pharmacology & Therapeutics|May 22, 2015
Population pharmacokinetics-pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's diseaseM Rosario, N L Dirks, M R Gastonguay, et al.
Pageof 2